研究论文

基于生物合成途径改造的一个三欣卡辛类似物的发现

  • 漆丽华 ,
  • 张媚 ,
  • 潘海学 ,
  • 陈晓东 ,
  • 唐功利
展开
  • a 江西中医药大学药学院 南昌 330004;
    b 中国科学院上海有机化学研究所 生命有机化学国家重点实验室 上海 200032

收稿日期: 2014-03-13

  修回日期: 2014-03-24

  网络出版日期: 2014-04-02

基金资助

国家自然科学基金(No.81202442)资助项目.

Production of a Trioxacarcin Analogue by Engineering of Its Biosynthetic Pathway

  • Qi Li-Hua ,
  • Zhang Mei ,
  • Pan Hai-Xue ,
  • Chen Xiao-Dong ,
  • Tang Gong-Li
Expand
  • a College of Pharmacy, Jiangxi University of Traditional Chinese Medicine, Nanchang 330004;
    b State Key Laboratory of Bio-organic and Natural Products Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 200032

Received date: 2014-03-13

  Revised date: 2014-03-24

  Online published: 2014-04-02

Supported by

Project supported by the National Natural Science Foundation of China (No. 81202442).

摘要

三欣卡辛是一种来源于链霉菌的具有良好抗肿瘤活性的芳香聚酮类天然产物. 我们通过对三欣卡辛的发酵和分离条件进行优化,显著地提高了其产量. 通过对基因簇中一个酰基转移酶(Trx49)编码基因的敲除,改动了三欣卡辛的生物合成途径,获得了C-4位糖基上O-乙酰基缺失的三欣卡辛类似物1. 体外细胞毒性测试考察糖基上的O-乙酰基修饰缺失对三欣卡辛的影响,发现化合物1的生物活性比三欣卡辛A有所降低,但仍具有IC50为4.86 nmol·L-1的优异抗肿瘤细胞活性.

本文引用格式

漆丽华 , 张媚 , 潘海学 , 陈晓东 , 唐功利 . 基于生物合成途径改造的一个三欣卡辛类似物的发现[J]. 有机化学, 2014 , 34(7) : 1376 -1381 . DOI: 10.6023/cjoc201403032

Abstract

Trioxacarcins, derived from streptomyces, are aromatic polyketide natural products with antitumor activity. The production of trioxacarcins was improved significantly by optimizing the fermentation and purification processes. The biosynthetic pathway of trioxacarcins was changed by inactivating an acyltransferase (Trx49) gene in the trioxacarcin cluster, and an analogue compound 1 lacking the O-acetyl group of sugar on C-4 was obtained. The influence of the O-acetyl group on biological activity of trioxacarcins was investigated by in vitro cytotoxicity test. Compared with trioxacarcin A, the activity of compound 1 decreases to some extent but still persists an excellent anti-tumor activity level with IC50 value of 4.86 nmol·L-1.

参考文献

[1] Tomita, F.; Tamaoki, T.; Morimoto, M. J. Antibiot. 1981, 34, 1519



[2] Tamaoki, T.; Shirahata, K.; Iida, T.; Tomita, F. J. Antibiot. 1981, 34, 1525



[3] Maskey, R. P.; Helmke, E.; Kayser, O.; Fiebig, H. H.; Maier, A.; Busche, A.; Laatsch, H. J. Antibiot. 2004, 57, 771



[4] Pfoh, R.; Laatsch, H.; Sheldrick, G. M. Nucleic Acids Res. 2008, 36, 3508



[5] Švenda, J.; Hill, N.; Myers, A. G. Proc. Natl. Acad. Sci. U. S. A. 2011, 108, 6709



[6] Magauer, T.; Smaltz, D. J.; Myers, A. G. Nat. Chem. 2013, 5, 886.



[7] Thibodeaux, C. J.; Melançon, C. E.; Liu, H. W. Angew. Chem., Int. Ed. Engl. 2008, 120, 9960



[8] García, B.; González-Sabín, J.; Menéndez, N.; Braña, A. F.; Núñez, L. E.; Morís, F.; Salas, J. A.; Méndez, C. Microb. Biotechnol. 2011, 4, 226



[9] Ro, D. K.; Paradise, E. M.; Ouellet, M.; Fisher, K. J.; Newman, K. L.; Ndungu, J. M.; Ho, K.A.; Eachus, R. A.; Ham, T. S.; Kirby, J.; Chang, M. C.; Withers, S. T.; Shiba, Y.; Sarpong, R.; Keasling, J. D. Nature 2006, 440, 940



[10] Xie, X.; Wong, W. W.; Tang, Y. Metab. Eng. 2007, 9, 379

文章导航

/